Disparate effects of antidiabetic drugs on arterial contraction

Metabolism: Clinical and Experimental

Volumn 46, Issue 10, 1997, Pages 1199-1205

  Peuler, Jacob D ^a   Miller, John A ^b   Bourghli, Mahmoud ^b   Zammam, Hassan Y ^b   Soltis, Edward E ^b   Sowers, James R ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; NORADRENALIN; PIOGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HYPERTENSION; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; MEMBRANE DEPOLARIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030808637     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90217-1     Document Type: Article

References (51)

1. Morgan DA, Mark AL: Contrasting effects of a biguanide and a sulfonylurea on arterial pressure in spontaneously hypertensive rats. Hypertension 22:452, 1993 (abstr)
2. Peuler JD, Johnson BAB, Phare SM, et al: Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats. Hypertension 22:214-220, 1993
3. Schmitt JK, Moore JR: Hypertension secondary to chlorpropamide with amelioration by changing to insulin. Am J Hypertens 6:317-319, 1993
4. Nolan JJ, Ludvik B, Beerdsen P, et al: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
5. Lee M-K, Miles PDG, Khoursheed M, et al: Metabolic effects of troglitazone on fructose-induced insulin resistance in rat. Diabetes 43:1435-1439, 1994
6. Pershadsingh HA, Szollosi J, Benson S, et al: Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension 21:1020-1023, 1993
7. Yoshioka S, Nishino H, Shiraki T, et al: Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism 42:75-80, 1993
8. Zhang HY, Reddy SR, Kotchen TA: Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension 24:106-110, 1994
9. Buchanan TA, Meehan WP, Jeng YY, et al: Blood pressure lowering by pioglitazone: Evidence for a direct vascular effect. J Clin Invest 96:354-360, 1995
10. Giugliano D, De Rosa N, Di Maro G, et al: Metformin improves glucose lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care 16:1387-1390, 1993
11. Landin K, Tengborn L, Smith U: Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med 229:181-187, 1991
12. Giugliano D, Quatraro A, Consoli G, et al: Metformin for obese, insulin-treated diabetic patients: Improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 44:107-112, 1993
13. Haupt E, Knick B, Koschinsky T, et al: Oral antidiabetic combination therapy with sulphonylureas and metformin. Diabete Metab 17:224-231, 1991
14. Mendoza SG, Faieta A, Carrasco H, et al: Metformin lowers blood pressure, insulin resistance, triglycerides and endogenous estradiol in hypertensive men. Clin Res 42:336A, 1994 (abstr)
15. Velazquez EM, Mendoza S, Hamer T, et al: Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism:43:647-654, 1994
16. Chan JCN, Tomlinson B, Critchley JAJH, et al: Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care 16:1035-1038, 1993
17. Montaguti U, Celin D, Ceredi C, et al: Efficacy of the long-term administration of metformin in hyperlipidaemic patients. Res Clin Forums 1:95-103, 1979
18. Verma S, Bhanot S, McNeill JH: Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats. Am J Physiol 267:H1250-H1253, 1994
19. Verma S, Bhanot S, McNeill JH: Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther 271:1334-1337, 1994
20. Bhalla RC, Toth KF, Tan E, et al: Vascular effects of metformin: Possible mechanisms for its antihypertensive action in spontaneously hypertensive rat. Am J Hypertens 9:570-576, 1996
21. Verma S, Bhanot S, McNeill JH: Decreased vascular reactivity in metformin-treated fructose-hypertensive rats. Metabolism 45:1053-1055, 1996
22. Nelson MT, Patlak JB, Worley JF, et al: Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 259:C3-C18, 1990
23. Sharma RV, Bhalla RC: Metformin attenuates agonist-stimulated calcium transients in vascular smooth muscle cells. Clin Exp Hypertens 17:913-929, 1995
24. Gund C, Webb RC: The insulin-sensitizing agent CS-045 inhibits contraction of rat vascular smooth muscle. Hypertension 26:553, 1995 (abstr)
25. Kotchen TA, Zhang HY, Reddy SR, et al: Effect of pioglitazone on vascular reactivity in vivo and in vitro. Am J Physiol 270:R660-R666, 1996
26. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267:E187-E199, 1994
27. Soltis EE, Newman PS, Olson JW: Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension. Hypertension 18:85-92, 1991
28. Rajanagam MAS, Medgett IC: Greater activation of smooth muscle alpha-2 adrenoceptors by epinephrine in distal than in proximal segments of rat tail artery. J Pharmacol Exp Ther 240:989-997, 1987
29. Medgett IC, Langer SZ: Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. J Pharmacol Exp Ther 229:823-830, 1984
30. Dashwood M, Jacobs M: Audioradiographic study of the α-adrenoceptors of rat aorta and tail artery. Eur J Pharmacol 115:129-130, 1985
31. Alexander WD, Oake RJ: The effect of insulin on vascular reactivity to norepinephrine. Diabetes 26:611-614, 1977
32. Peuler JD, Ravi J, Boggaram B, et al: Interactive effects of insulin with dihydrotestosterone on adrenergic tone in isolated rat tail arterial rings. Am J Hypertens 9:860-866, 1996
33. Miller JA, Peuler JD: Rapid vasorelaxation by high levels of metformin. FASEB J 10:A700, 1996 (abstr)
34. Zammam HY, Soltis EE, Sowers JR, et al: Effects of insulin-sensitizing drugs on arterial contractile responses. Hypertension 24:403, 1994 (abstr)
35. Peuler JD, Phare SM, Iannucci AR, et al: Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle cell proliferation. Am J Hypertens 9:188-192, 1996
36. Bunting CE, Koschinsky T, Rütter R, et al: Metformin inhibits the growth of human vascular cells - A new potentially antiatherogenic drug effect. Diabetologia 29:523A, 1986 (abstr)
37. Caro JF, Ittoop O, Sinha MK: Glyburide but not ciglitazone enhances insulin action in the liver independent of insulin receptor kinase activation. Metabolism 38:606-611, 1989
38. Pezzino V, Trischitta V, Purrello F, et al: Effect of metformin on insulin binding to receptors in cultured human lymphocytes and cancer cells. Diabetologia 23:131-135, 1982
39. Fischer Y, Thomas J, Rosen P, et al: Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology 136:412-420, 1995
40. Kobayashi M, Iwanishi M, Egawa K, et al: Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41:476-483, 1992
41. Purrello F, Gullo D, Brunetti A, et al: Direct effects of biguanides on glucose utilization in vitro. Metabolism 36:774-776, 1987
42. Kletzien RF, Clarke SD, Ulrich RG: Enhancement of adipocyte differentiation by an insulin sensitizing agent. Mol Pharmacol 41:393-398, 1992
43. Prince MJ, Olefsky JM: Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors. J Clin Invest 66:608-611, 1980
44. Montanari G, Bondioli A, Rizzato G, et al: Treatment with low dose metformin in patients with peripheral vascular disease. Pharmacol Res 25:63-73, 1992
45. Petersen JS, DiBona GF: Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats. Hypertension 27:619-625, 1996
46. Muntzel MS, Petersen JS: Metformin lowers arterial pressure by activating sympathetic withdrawal in spontaneously hypertensive rats (SHR). FASEB J 10:A568, 1996 (abstr)
47. +ATPase in vascular smooth muscle cells (VSMC). Am J Hypertens 6:626-629, 1993
48. 2+-ATPaSe expression. J Vasc Med Biol 4:79-84, 1993
49. Dominquez LJ, Davidoff AJ, Srinivas PR, et al: Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle. Endocrinology 137:113-121, 1996
50. Christensen NJ: Acute effects of insulin on cardiovascular function and noradrenaline uptake and release. Diabetologia 25:377-381, 1983
51. Webb RC, Vanhoutte PM, Bohr DF: Adrenergic neurotransmission in vascular smooth muscle from spontaneously hypertensive rats. Hypertension 3:93-103, 1981